Medistim ASA (OB:MEDI) Released Earnings Last Week And Analysts Lifted Their Price Target To kr255
Shareholders of Medistim ASA (OB:MEDI) will be pleased this week, given that the stock price is up 15% to kr263 following its latest second-quarter results. It was a workmanlike result, with revenues of kr169m coming in 3.7% ahead of expectations, and statutory earnings per share of kr5.67, in line with analyst appraisals. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual. Readers will be glad to know we’ve aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Medistim after the latest results.
